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The purpose of this study was to identify and confirm 
biochemically three phases of the menstrual cycle in 14 well 
conditioned athletes and then to examine the effects of the 
various phases on work capacity, perceived exertion and 
lactic acid accumulation following individualized work 
tasks. Radioimmunoassays of plasma estradiol and proges- 
terone were used to confirm the midluteal and mid-follicular 
phases of the cycle. Subjects performed a 12 minute sub- • 
maximal work task consisting of 3 minutes at 60%, 3 minutes 
at 70% and 6 minutes at 80% of their measured maximum work 
capacity. Perceived exertion was recorded every 2 minutes 
using the Borg 15 Point Scale. After a 15 minute rest the 
subjects were asked to run as long as they could at a work 
rate corresponding to 100% of their maximum work capacity. 
Blood samples were drawn for lactic acid assays prior to the 
start of the initial run, 2 minutes after the sub-maximal 
run and 5 minutes after the run to exhaustion. 
The phase of cycle had no influence on perceived exer- 
tion or on lactic acid accumulation. Maximum run times to 
exhaustion increased significantly (p < .05) in the mid- 
follicular and midluteal phases when compared to day 1. The 
average increases were 17.9% and 40.2% respectively. These 
findings indicate that work capacity is maximal in the 
midluteal phase. 
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CHAPTER I 
INTRODUCTION 
Statement of the Problem 
The purpose of this study was to identify and confirm 
biochemically three phases of the menstrual cycle in well- 
conditioned athletes and then to examine the effect of the 
various phases on work capacity, perceived exertion and 
lactic acid accumulation following assigned work tasks. 
Significance of the Study 
Female athletes have long held that they were at a 
disadvantage whenever required to compete while menstruating, 
A corollary to this has been the belief that they fared 
better in competitions scheduled at a time when they were 
not menstruating. Many studies have been carried out to 
test the relationship between the phases of the menstrual 
cycle and maximal physical performance. Some studies have 
concluded that menstruation adversely affected performance 
in activities such as gymnastics and tennis, while other 
studies have found menstruation to have little or no effect 
on performance in swimming or cycling (Doolittle and 
Engebretsen, 1972? Garlick and Bernaver, 1968; Scott and 
Tuttle, 1932). Still other studies were unable to find any 
relationship between the phase of cycle and achievement 
(Erdelyi, 1962; Pierson and Lockhart, 1963). Some of the 
confusing or contradicting conclusions may have been caused 
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by the inaccurate calendar method of identifying the phases 
of the cycle. Errors in assigning phases may have produced 
a masking effect on bonafide cycle-related performance 
variations (Doolittle and Engebretsen, 1972; Gamberale, 
Strindberg and Wahlberg, 1975; Wearing, et al 1972). 
In recent years, it has become possible to confirm 
biochemically the midfollicular and midluteal phases. 
Radioimmunoassays of plasma levels of 17-B estradiol (E-2) 
and progestrone (P) allow the measurement of levels typical 
of these phases (Henry, 1970; Ros et al 1970). Both E-2 and 
P are present in low-levels during menstruation. By the 
time the midpoint of the follicular phase has been reached, 
the E-2 level, but not the P level has become elevated. At 
the middle of the luteal phase, levels of both E-2 and P are 
very elevated. 
The phases under observation were day 1 of menses, the 
midfoilicular phase (day 7 + 1) and the midluteal phase 
(day 21 +1) of the menstrual cycle. The maximal work 
capacity was determined for each subject and the perception 
of effort to perform at 80% of maximal work capacity was 
recorded during each phase of her cycle. 
Findings from this study could help predict whether an 
athlete's performance in a strenuous event might be better 
if the event took place at a time when she was in one 
identified phase rather than in some other phase of her 
menstrual cycle. Positive findings might suggest that the 
athlete's menstrual cycle be interrupted or influenced by 
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use of oral contraceptives, so that at a time of a major 
competition the athlete would be in a phase of her cycle 
when her capacity to perform was optimal. 
Delimitations 
Fourteen well conditioned female athletes ranging in 
age from 18 to 34 with 'normal' regular cycles were tested 
over two mentrual cycles. No subject was taking oral contra- 
ceptives. (Data are included on one additional subject who 
was on oral contraceptives, but her test findings were kept 
separate and are indicated by an asterisk.) Diurnal varia- 
tions in hormones were avoided by not varying the time of 
conducting the tests for each subject. Subjects were 
instructed not to eat for 3 hours before commencing a test 
session. All tests were carried out between 1700 hours and 
2000 hours for each subject. To eliminate any training or 
practise effects on performance in a particular cycle phase, 
5 subjects started the testing program at day 1 of menses, 5 
others started at the midfollicular phase, and 4 started at 
the midluteal phase of their cycle. 
Limitations 
The study was conducted at the Paul Schwaan Fitness 
Center at the University of Regina in the period from 
November 15, 1982 to March 31, 1983. 
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Definitions 
Balke Treadmill Test is a measure of work capacity 
where subjects perform at a constant speed, while the incline 
of the treadmill is raised 2.5 degrees every 2 minutes, 
until the subject is unable to continue. 
Endurance Time refers to the number of seconds that a 
subject runs while performing at 100% of her work capacity. 
17-B Estradiol (E-2) is the hormone principally respon- 
sible for the development of female secondary sex character- 
istics. Blood levels of E-2 reach a peak just before 
ovulation, decline at the time of ovulation, and reach a 
second peak a few days after ovulation. 
Menses or menstruation is the periodic discharge from 
the vagina of blood and tissue from a non-pregnant uterus. 
Menstrual Cycle is the period from the onset of menses 
(day 1) to the day before the start of the next menses. The 
length of the cycle in the 14 subjects used varied from 26 
to 31 days, with a mean + standard error of 28.2 + 2 days. 
Met is the metabolic equivalent of the basal metabolic 
rate equal to 3.5 milliliters of oxygen per kilogram of body 
weight per minute. (1 Met = 3.5 ral/kg/min.) 
Midfollicular Phase of the menstrual cycle occurs 6 to 
9 days after the start of menstruation. It is the, midperiod 
of follicle growth preparatory to ovulation. It is charac- 
terized by very low levels of P and slightly elevated levels 
of E-2. 
5 
Midluteal Phase of the menstrual cycle occurs 20 to 23 
days after the start of menstruation. It is characterized 
by high levels of E-2 and high levels of P in the circulating 
blood. 
Perceived Exertion (RPE) is a scaled estimate of how 
difficult a task is perceived to be by the subject. 
Progesterone (P) is the female hormone secreted by the 
corpus luteum commencing with ovulation. Its function is to 
prepare the uterus to receive a fertilized ovum. 
Lactic Acid (LA) is a metabolite produced in muscle 
tissue during anaerobic metabolism. 
Maximum Work Capacity (Wmax) is the highest work load 




REVIEW OF LITERATURE 
Physiological reasons have long been sought to explain 
the many reports of poor athletic performances by females 
just prior to or during menses (Erdelyi, 1964; Zaheieva, 
1965; and Webb, Millian and Stolz, 1979). 
Moore (1923) made daily measurements of the strength of 
eight muscle groups over many menstrual cycles. He concluded 
that during menstruation, the strength of each group of 
muscles was less than the stren^h in the intermenstrual 
periods. This finding was confirmed by studies of Howland 
(1936) and Keenan (1958). However, Carson (1966) found that 
only the strength of one muscle group was adyersely affected 
by menstruation, with other muscle groups being unaffected. 
Wearing et al, (1972) found that the best achievement in 
three tests of muscle strength were generally to be found 
about seven days prior to menstruation. Other studies found 
no changes in muscle strength that could be dependably 
related to the phase of the menstrual cycle (Auster, 1944; 
Rockwell, 1962; Petrofsky, 1976; Higgs and Robertson, 1981). 
Other investigators have examined the relationship 
between reaction times or movement times and the phase of 
the menstrual cycle. Dalton (1960) found that individuals 
had slower reaction times when menstruating. Gamberale 
(1975) and Hunter, et al (1979) found decision reaction- 
times were longer during menses. Other investigators found 
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that there were no changes in simple reaction time or move- 
ment time that could be associated with a particular phase 
of the mentrual cycle (Pierson and Lockhart, 1963; Koppel et 
al 1969). 
Possible variations in maximal cardiorespiratory 
capacity with a phase of the menstrual cycle have also been 
examined, Doolittle (1972) in a study using four performance 
tests each requiring near maximal cardiorespiratory output, 
found no measureable differences in performance over the 
course of the menstrual cycle. The findings of Phillips 
(1973) and Fox, et al (1969) also found no measureable 
differences when they measured metabolic and cardiorespira- 
tory responses to exercise. Allsen, Parsons and Bryee 
(1977) investigated maximal oxygen uptakes at each of four 
phases of the menstrual cycle, but found no significant 
differences. Heart rates and oxygen uptake at submaximal as 
well as at maximal work loads were found by Doolittle (1972) 
and Stephenson et al (1982) to be unrelated to phase of the 
menstrual cycle. Other investigators were unable to find a 
correlation between any phase of the menstrual cycle and the 
fluid volumes of hematocrit or the level of hemoglobin 
during exercise (Dintenfass, 1966; Garlich and Bernauer, 
1968; and Albohm, 1976). 
Psychological factors that might explain poor perfor- 
mance during menstruation were examined by a number of 
investigators. Pierson and Lockhart (1963) suggested that 
the poorer performances and higher rates of accidents among 
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menstruating women were due to discomfort and external 
distractions. They found a linear relationship existed 
between heart rate, oxygen consumption, and a subject's 
perception of effort (Borg, 1973; Morgan, 1973; Skinner, 
Hustler, Bergsteinova and Buskirk, 1973; Hage, 1981). 
Gamberale (1975) found that female athletes who suffered 
from dysmenorrhea perceived work to be more difficult imme- 
diately prior to or during the flow phase. This increase in 
perception of difficulty was recorded at work loads as low 
as 40% of the subject's work capacity. Petrofsky et al 
(1976) observed that some women using oral contraceptives, 
displayed no change in performance scores or perceived 
exertion over the course of a menstrual cycle when working 
at submaximal or maximal work loads. Other investigators 
found a distinct increase in perceived exertion of subjects 
performing at maximal capacity just prior to and on day 1 of 
menses, but found no increase in perceived exertion when 
performing submaximal work tasks (Gamberale et al, 1975; 
Higgs and Robertson, 1981; Stephenson et al, 1982). The 
expression of a subject's perception of exertion was refined 
to a 15 point scale by Borg (1982) to allow better standard! 
zation of this value (now referred to as RPE - achronym for 
ratings of perceived exertion). 
The inconsistent physiological explanations for poor 
performances during menses might have resulted from inaccur- 
ate recognition of the phase of cycle when the measurements 
were made (Doolittle et al, 1975). Confirmation of the 
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phase of cycle became possible with the advent of radioimmuno- 
assays and other very sensitive methods of measuring 
female hormones. Fluctuations that occur in the circu- 
lating levels of 17-B estradiol and progesterone over the 
course of a menstrual cycle are shown in Figures 1 and 2. 
Jurkowski, Jonas, Walker, Vounglai and Sutton (1978) used 
such measures to confirm the phase of cycle and went on to 
assess the effect of exercise on hormone levels, cardio- 
vascular output, and respiratory response at each phase of 
the cycle. Subjects exercised in a progressive manner.for 
20 minutes at both 30-35% and 60-66% of maximum power output. 
This was followed immediately by a 85-95% effort to exhaus- 
tion. No differences in the maximal work load achieved, 
heart rate, or ventilation, could be associated either with 
the low levels of estradiol and progesterone in the folli- 
cular phase, or with the high levels of both hormones during 
the luteal phase. The circulating levels of estradiol and 
progesterone were found to be dependent upon both the 
intensity of the exercise and upon the phase of the menstrual 
cycle. Estradiol levels increased during exercise in both 
phases, the greatest increase occurring at maximal exercise 
intensities. Progesterone followed this pattern during the 
luteal phase, but during the follicular phase levels remained 
low regardless of exercise intensity. Bonen and Belcastro 
(1978) found similar responses of these hormones to exercise 
during the follicular and luteal phase, but found that the 











Figure 1. Variation of plasma progesterone over the course of 16 presumptive ovulatory 
cycles, synchronized around the day of the LH midcycle peak. Shaded area 
represents 95% confidence limits around means (bold line) (Ross, G.T., 
Cargille, C.M., Lipsatt, M.B., Rayford, P.L., Marshall, 3.R., Strait, C.A., 
and Rodbard, D, Pituitary and Gonadal Hormones in Women. Recent Progress 










Figure 2. Evolution of 17 ^ estradiol during the course of the menstrual cycle. The 
cycle is centered on the mid LH peak. (Modified from Franchimont, P., 
Valcke, 3.C., and Lambotte, R. Evaluation of Endocrine Function. In 
3.0. Henry (Editor). Clinical Diagnosis and Management by Laboratory 
Methods, W.B. Saunders Co., 1979.) 
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Jurkowski et al (1978) found that the time to exhaustion 
at 90% of maximum work load was significantly longer during 
the luteal phase than in the follicular phase. It had been 
suggested thatf since the progesterone and estradiol are at 
their highest levels during the luteal phase, they might 
alter performance capacity through effects on substrate 
metabolism (Bonen, Ling, MacIntyre, Neil, McGrail and 
Balcastro, 1979). It would follow that the low levels of 
both hormones during menses might account for the performance 
decrements experienced by many females at time of menses. A 
further study by Jurkowski (1982) found that plasma lactate 
was higher in response to heavy and exhaustive exercise 
during the follicular phase than in the luteal phase. This 
higher plasma lactate could be due either to higher rate of 
production, or due to slower removal by liver or kidney 
under altered hormone level. 
One theory is that high circulating hormone levels of 
progesterone and estradiol in the mid-luteal phase may 
facilitate an augmented response during exercise, which 
somehow at high exercise intensities results in a more rapid 
removal of lactic acid and increased work-time to exhaustion 
(Higgs, Note 1). Another theory is that the high levels of 
ovarian hormones in the blood during exercise facilitate 
improved performance by either (a) enhancing oxidation of 
fatty acids thereby delaying glycolytic metabolism, or 
(b) improving utilization of oxygen in the muscle (Jurkowski, 
1982). 
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In conclusion, there appear to have been few studies 
in the literature that have dealt with the influence of the 
various phases of the menstrual cycle on athletic performance 
when the phases of the menstrual cycle were biochemically 
confirmed. There is a need for studies which biochemically 
confirm the phases to ensure accurate assignment of each 
menstrual phase when tests are performed. With the use of 
individualized work tasks, it might be possible for a 
performance high point to be more clearly identified with 
some phase of the menstrual cycle. 
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CHAPTER III 
METHODS AND PROCEDURES 
Research Design 
An individualized subject design employing repeated 
measures at three recognizable phases of the menstrual cycle 
was used to investigate possible related performance changes. 
Performances were compared on the first day of menstruation, 
in the midfoilicular phase, and in the midluteal phase. The 
performance parameters investigated were ratings of perceived 
exertion during a twelve minute submaximal run, and a timed 
run-to-exhaustion at each individual's maximal work capacity. 
Blood for lactic acid assays were drawn 2 minutes after 
completion of the submaximal run and again 5 minutes after 
completion of the run-to-exhaustion. Assessments and measure 
ments were made over 2 menstrual cycles so that the consis- 
tency or variability of each individual's performance could 
be recognized. 
The Subjects 
Fourteen healthy, physically well-conditioned female 
athletes ranging in age from 18 to 33 years served as 
subjects. (Data are included on a fifteenth subject who was 
on oral contraceptives. Her data was kept separate and are 
indicated by an asterisk.) The predicted MVO2 for the 
subjects ranged from 39.2 ml/kg/min to 53.6 ml/kg/min with 
the average being 46.0 ml/kg/min. All subjects were 
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questioned regarding medical and menstrual history 
(Appendix A). All were deemed to be healthy and to have 
cycles falling within normal limits. 
The study was conducted over a five month period, 
November 1982 through March 1983. During this time subjects 
agreed to maintain a constant activity level. All testing 
was conducted at the Dr. Paul Schwaan Fitness Centre at the 
University of Regina. Each subject was tested at the same 
time of day throughout the study, and all testing sessions 
were completed within 24 hours of the target day. The order 
of introduction to testing was varied so that five subjects 
had their first test on day 1 of menstruation, four were 
first tested in their midfollicular phase, and five were 
first tested in the midluteal phase. The subject on oral 
contraceptives entered the study on day 1 of menstruation. 
Establishing Work Intensities 
Prior to entrance into the study, individual maximal 
work capacities were assessed during days 7-9 of the 
menstrual cycles, using the modified Balke Treadmill Test 
(Liss, 1980). 
Work capacities were measured on a Quinton power driven 
treadmill. Individuals selected a starting speed with which 
they were comfortable. The speed was held constant and the 
inclination was increased 2.5 degrees every 2 minutes until 
the subject was no longer able to continue. All subjects 
were made aware of the importance of giving an all out 
effort., 
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An individual was considered to have successfully 
completed a given work load if she had maintained that work 
load for a minimum of one and a half minutes. The highest 
work load successfully maintained was regarded as the 
individual’s maximal work load as measured in METS (Table 1). 
The MET value indicated by the maximal work load was used to 
determine work levels for the 12 minute submaximal runs. 
Perceived Exertion (RPE) 
Perceived exertion was estimated using the Borg 15 
Point Scale (Appendix B). The instrument was constructed 
using numbers ranging from 6 to 20, with work intensity 
categories assigned to odd numbers. Several studies agree 
that RPE values increase linearly with intensity of work 
(Borg and Linderholm, 1967; Gamberale, 1972; Borg, 1982; 
Morgan, 1973). 
Perceived exertion was defined for the subjects as "how 
hard or difficult the exercise feels to you". They were 
informed that a score of 6 represented a comfortable sitting 
or standing value and a score of 20 represented complete 
exhaustion or inability to continue work. The scale was 
placed in front of the treadmill during determination of 
work capacity, and subjects were asked to constantly assign 
values to the work they were doing. 
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Table 1 
Relative Energy Expenditure in METS 
for Graded Exercise 
(Modified Balke Treadmill Test) 
Grade % Duration Expenditure in METS* 
Speed 












































*MET Calculation 1 MET = 3.5 ml/kilogram/min (of oxygen cost) 
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Basal Body Temperature 
All subjects were supplied with a basal body thermometer 
and agreed to record basal body temperature each morning 
before getting out of bed. A sustained increase in basal 
body temperature of at least 0.3 degrees Celsius was used as 
an indicator that ovulation was taking place. Testing for 
the midluteal phase was conducted 7 days following the 
temperature rise. Cycle phase was confirmed through analysis 
of the hormones progesterone and estradiol in venous blood. 
Progesteroney Estradiol and Lactic Acid Measures 
Venous blood samples were drawn by a Registered Medical 
Laboratory Technologist. Three samples were drawn from each 
subject at each session. The first sample was collected 
while the subject was at rest prior to the start of each 
test session, the second sample was drawn 2 minutes following 
the submaximal work task, the third specimen was drawn 
5 minutes following the work task to exhaustion. 
Blood samples were drawn into 5 ml heparinized vacuum 
tubes. To prevent clotting, the tubes containing the whole 
blood were mixed by inverting them 10-15 times in a one 
minute period. Exactly one millilitre of the heparinized 
whole blood was then removed with an Eppendorf pipette and 
injected into a clean 16 mm x 125 mm glass tube containing 
2 ml of ice cold 0.6M perchloric acid. The tube was stop- 
pered with a paraffin waxed cork, mixed well by shaking, and 
placed in an ice water bath for a minimum of 5 minutes. At 
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that time the tubes, containing the 1 ml of whole blood in 
2.0 ml of perchloric acid, were centrifuged in an I.E.C. 
clinical angle head centrifuge. The tubes were spun at 
2000 r.p.m. for a minimum of 5 minutes. The supernates were 
transferred to separate clean glass tubes and placed in a 
refrigerator for analysis of lactic acid within 24 hours, or 
frozen at -20 degrees Celsius for delayed batch analysis. 
The plasma supernate was used for analysis of progesterone 
and estradiol levels. 
All analyses of the hormones progesterone and estradiol, 
and blood lactate levels were performed under contract by 
the Saskatchewan Provincial Health Laboratories. Estradiol 
was assayed by radiommunoassay using Pantex immuno-Estradiol 
125-1 kits (Appendix C). Progesterone was analyzed by a No- 
Extraction radioimmunoassay with reagents purchased from 
Diagnostic Products Corporation (Appendix D). Lactic acid 
was assayed on an Abbott 200 analyzer using procedures and 
reagents detailed by Sigma (Appendix E). Controls and 
blanks on all assays were monitored carefully in compliance 
with standard techniques. 
Cycle Testing 
Upon reporting to the laboratory, subjects completed a 
daily living questionnaire, were weighed, and had the resting 
blood sample drawn. Subjects then performed a continuous 
12 minutes submaximal work task involving 3 minutes at each 
of 60% and 70% of their maximal work capacity, and 6 minutes 
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at 80% of their maximal work capacity. Subjects were 
reminded to give ratings of perceived exertion that reflected 
how difficult the task felt to them at that moment. Ratings 
of exertion were recorded at the end of every 2 minutes 
(Appendix F). The 12 minute work task was followed by a 
fifteen minute rest period during which time the subject 
remained seated. The second blood sample was drawn 2 minutes 
into the rest period. 
The timed run to voluntary exhaustion at 100% of the 
individuals maximum work capacity followed the rest period. 
Subjects were encouraged to work as long as possible, and it 
was stressed that every second was important. Time into the 
work task was announced every 30 seconds, and gentle verbal 
encouragement was given when subjects started to struggle. 
The third blood sample was collected five minutes after 
the termination of this run. Subjects remained in the 
laboratory until fully recovered. 
Data Analysis 
Graphs were prepared to illustrate any trends in the 
various parameters in each individual over the period of 
2 cycles. Individual data have been presented in tabular as 
well as in graphic form. Described are ratings of perceived 
exertion, maximal run time, and pre- and post work levels of 
blood lactic acid at each of the three phases of the 
menstrual cycle. Within subjects average values have been 
used in a one-way analysis of variance (ANOVA for the 
21 
repeated measures of mean RPE, mean lactic acid and mean all 
out performance time). Any significant differences revealed 




Description of Subjects 
Subjects ranged in age from 18 to 33, and all were 
deemed to have cycles falling within normal limits. The 
predicted maximum oxygen consuption ranged from 39.2 ml/kg/ 
min to 53 ml/kg/min, with an average for the group of 
46.0 ml/kg/min. All subjects were actively involved in some 
form of athletic activity at least 3 times per week. 
Personal data for each subject can be seen in Table 4. 
Hormonal Confirmation of Phase of Cycle 
Measures of the resting levels of plasma progesterone 
and plasma estradiol were utilized to confirm the stage of 
each subjects menstrual cycle when her performance was 
being assessed. Some authors claim hormone levels may be 
affected by exercise (Bonen and Belcastro, 1978), therefore, 
blood for hormone analysis was collected at rest prior to 
commencement of exercise. 
Lowest values of progesterone are observed during the 
follicular (preovulatory) phase of the normal menstrual 
cycle. The level increases sharply after the mid-cycle peak 
of luteinizing hormone, becoming very high in the luteal 
phase at or around 21 days of the cycle. Levels fall off 
sharply towards base-line by the onset of menstruation. The 
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level of progesterone does not invariably return to base- 
line values before the onset of menstruation, so low levels 
of progesterone found at day 1 of menses may not be as low 
as levels found at day 7 (Yen et al 1970). 
Estradiol levels follow a biphasic pattern over the 
menstrual cycle. From a low of less than 200 pmol/L at day 
1, the level slowly increased until about day 7 when levels 
up to 400 pmol/L may be found. The estradiol levels then 
rose sharply to reach a maximum as high as 1200 praol/L at 
mid-cycle, sometimes designated as the 'ovulatory peak'. 
Levels then fell off for a few days before they increased to 
a second but lower peak in the luteal or "premenstrual 
phase". This second peak developed at about 21 days 
(midluteal phase) of the normal menstrual cycle (Speroff and 
Vande Wiele, 1971). 
Reviews of simultaneous measures of estradiol (E-2) 
and progesterone (P) levels allowed confirmation of the 
phases of the cycle for all participants at day 1, midfolli- 
cular, and midluteal. For example: on day 1, both E-2 and 
P are low; at midfoilicular phase the E-2 is low but higher 
than on day 1 and P is low, possibly lower than on day 1; at 
midluteal phase both and P are very elevated. 
Actual levels used to discriminate are shown in 
Tables 2a and 2b. 
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Table 2a 
Estradiol and Progesterone Plasma Levels to 
Confirm Phase of Menstrual Cycle 
Range of Normals Day 1 of Menses 
E2 very low 
(<200 pmol/L) 
P very low 
(<4 nmol/L) 
Subjects 2 cycles 
Midfollicular Phase 
E2 low but about 
double day 1 level 
(150 - 350 pmol/L) 




E2 elevated generally 
above midfollicular 
level 
300 - 700 pmol/L) 
P very elevated 

























































































Range of Normals 
Estradiol and Progesterone Plasma Levels to 
Confirm Phase of Menstrual Cycle 
Subjects 2 cycles 
Day 1 of Menses 
E2 very low 
(^200 pmol/L) 




E2 low but about 
double day 1 level 
(150 - 350 pmol/L) 
P very low 
(<4 nmol/L) 
Mldluteal Phase 
E2 elevated generally 
above midfollicular 
level 
300 - 700 pmol/L) 
P very elevated 













































































♦Subject using oral contraceptive 
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Determination of Maximum Work Capacity and Ratings of 
Perceived Exertion 
Each subject's perception of stress experienced (RPE) 
during the 12 minute run are recorded in Table 3 for runs 
made on first day, midfoilicular, and midluteal phases of 
two menstrual cycles. The determined maximum work capacity 
and treadmill settings for the 12 minute run assigned each 
subject are recorded in Table 4. 
Maximal Run Time (MRT) 
The individualized work loads used during the 12 minute 
run and the run to exhaustion are shown in Table 4. The 
maximum running times (MRT) at 100% of work capacity for 
each subject are shown in Table 5. The changes in MRT of 
each subject as they progressed through their cycles are 
illustrated in Figures 3a to 3c. The lines are drawn through 
the averages of running times at corresponding phases of 
each of the two menstrual cycles. Variations of run times 
found in each of two cycles are illustrated by vertical 
bars. To check for a possible relationship between the 
estradiol level for each subject and her MRT, comparisons of 
MRT were made at day 1 when the estradiol level was lowest, 
and at the midfoilicular and midluteal phases when the 
estradiol levels were highest. 
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Table 3 
Perceived Exertion at Minutes Into Submaxima I 




Perceived Exertion at Minutes Into Submaxima I Run 
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Day 1 MIdfolIicular HIdluteal 
Igure 3a, Run times to voluntary exhaustion at lOOJ work capacity at Day 1, MIdfol Mcuiar 
and MIdluteal phases of the menstrual cycle. ' 


























Day 1 MidfolIIcular Midluteal 
Figure 3b. Run times to voluntary exhaustion at lOOjC work capacity at Day I, MidfoMicular 
and Midluteal phases of the menstrual cycle. 
























Day Midfoi I Icular Mldlutea-I 
Figure 3c, Run times to voluntary exhaustion at lOOJf work capacity at Day 1, MidfoMIcular 
and Mid luteal phases of the menstrual cycle. Subject 15 was using oral 
contraceptives, 
I throijnh means of values found on two consecutlve cycles. 
Tablo 5 
Maxinval Run Time and Phase of Cycle 
Subject 
Maximum Run Time (seconds) 
Cay I MIdfo 111cular Mid luteal 
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on oral contraceptives 
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Blood LA levels were compared at each phase of the 
cycle. 
A summary of the ANOVA one-way analysis of variance 
with each phase of the cycle for each subject's mean MRT, 
mean RPE, mean LA, mean E-L and mean P is shown in Table 7. 
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Table 6 
Lactic Acid Levels mmol/L at rest, After Submaximal Run, and 
After Run to Voluntary Exhaustion at Day 1, Midfollicular and 
Midluteal Phases of the Normal Cycle of 15 Subjects. 
 Day 1  Midfollicular Midluteal 
Subject #1 - Rest .8 1.3 1 1.4 0.9 0.8 
Sub Max 2.1 1.6 1.6 1.2 1.3 1.6 
 Max  7.5 6.8 7.3 7.1 8.6 7.2 
Subject #2 - Rest 1.0 1.2 1.4 1.1 .7 1.0 
Sub Max 3.1 2.9 2.3 2.5 3.2 2.4 
 Max  9.6 9.4 8.2 7.1 7.6** 8.6 
Subject #3 -Rest 1.0 1.0 1.8 1.4 1.7 1.6 
Sub Max 1.8 2.1 2.8 1.8 1.2 2.1 
 Max 7.2 6.2 9^J 9^2 8.2 6.9** 
Subject #4 - Rest .8 1.0 1.1 ND*** 1.3 ND 
Sub Max 1.8 2.3 1.8 ND 1.8 ND 
 Max 12.7 11.4 10.9 ND 10.3 ND 
Subject #5 - Rest 2.3 ND 0.9 0,9 0.8 0.8 
Sub Max 2.9 ND 2.0 1.8 1.8 1.9 
  Max 7^0 ND 7_;8 7jj6 6^;9 6.6 
Subject #6 - Rest 1,1 0,4 0,9 0.7 0.7 0.4 
Sub Max 1.8 1.8 1.7 1.7 2.0 3.6 
 Max 9.8 9.9 8.5 9.1 6.0** 10.1 
Subject #7 - Rest 0.7 0.9 1.8 2.1 1 .1 1.1 
Sub Max 6.2 6.2 7.6 5.3 7.5 5.4 
 Max 6.3 10.2 11 .3 9.2 8^J 8.0 
Subject #8 - Rest 1.2 1.3 1.3 0.8 1.1 1.0 
Sub Max 1,7 1.8 1.4 0.9 1.3 1.7 
 Max 11.7 8.4 8.3 11.1 7.0 7.1 
Subject #9 - Rest 0.9 0.6 1.0 0.9 0.9 1.0 
Sub Max 3.4 3.4 3.7 3.5 4.6 4.1 
 Max 11.5 8.0 10.1 9£j 14.3 13.4 
Subject #10 - Rest ND 1.0 0.7 ND 0.8 1.1 
Sub Max ND 1.2 1.0 ND 1.3 1.3 
 Max ND 8_^0 7^9 ND  8.4 8.1 
Subject #11 - Rest 0.7 0.7 1.0 0.7 0.8 0.7 
Sub Max 1.1 1.0 1.7 1.0 1.6 1.0 
 Majc 8.8 10.2 8^5 8^9 6.7** 10.9 
Subject #12. - Rest 1.0 ND 1.6 0.6 1.1 1.0 
Sub Max 1.3 ND 1.7 1.5 1.6 2.6 
 Ma^c 9^3 ND 10.6 9^_7 9.8 10.1 
Subject #13 - Rest 0.8 0.6 0.7 0.7 0.9 0.8 
Sub Max 2.4 4.7 2.8 3.9 3.6 3.4 
 Majc 7.6 7.4 10.0 8.7 8.2 8.1 
Subject #14 - Rest 0.7 0.9 0.7 0.8 1.6 0.9 
Sub Max 2.6 3.2 2.0 4.2 2.7 3.2 
. Max 9.8 8.6 9_^9 8^J 10.3 ND 
Subject #15* - Rest 0.8 0.7 0.9 0.8 0.8 0,7 
Sub Max 2.0 2.4 1.5 2.2 2.3 2.8 
 Max  7.9 8.4 8.7 10.6 10.0 
*on oral contraceptives 
**late blood sample 
***No Data (ND) 
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Table 7 
One Way Analysis of Variance of RPE, MRT, Lactic Acids, 
Estradiol and Progesterone with Phase of Menstrual Cycle 
Results-Means, F & P 
Variable Day 1 Midfollicular Midluteal 





























. 1 23 
Max Run Time 
(second) 226.1 268.9 317.1 7.048 
LA mmol/L 
1 (resting) 
2 (post sub max) 














1 (resting) 98.14 223.71 
2 (post sub max) 94.79 260.71 









2 (post sub max) 

































The purpose of this study was to determine whether 
there was any relationship between athletic performance and 
the biochemically confirmed phases of the menstrual cycle in 
female athletes, 
A number of studies have found that a large percentage 
of participants perform "less well" while menstruating 
(Dalton, 1960; ’"rdelyi, 1976; Higgs and Robertson, 1981; 
Moore and Barker, 1923; Wearing et al, 1972;). There is 
less agreement in the literature whether any one phase of 
the cycle favours maximal performance. It has been suggested 
that errors in assigning phases may have masked any relation- 
ship (Doolittle, 1972), Jurkowski et al (1978) were the 
first to use hormonal levels to confirm the cycle phases and 
relate them to work capacity. They confirmed the midfolli- 
cular (6-9 days after onset of menstruation) and the 
midluteal phase (6 - 9 days after ovulation) by measurement 
of plasma progesterone. Ovulation was indicated by a 
sustained increase of at least 0.3°C in basal body temper- 
ature. In the midfollicular phase the plasma levels of P 
are very low and generally equal to or less than 4 nmol/L. 
At the same time, E-2 levels are only moderately elevated 
and generally range between 150 and 350 pmol/L. In the 
midluteal phase, plasma levels of P are much higher and 
generally exceed 30 nmol/L while levels of E-2 are about 
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double those in the midfollicular phase and generally exceed 
300 pmol/L (Henry, 1979) . 
In this study measurements of P and E-2 were carried 
out at day 1, day 7+, and day 21+ of the cycle before work 
tasks were attempted. When the resting and P blood 
levels were not within expected limits for the midfollicular 
(day 7) and midluteal (day 21) phases, (see Tables 2a and 
2b), the performance measures were rejected and tests were 
repeated at a later menstrual cycle. Some 12 data sets were 
rejected because measures of E-2 or P were outside the 
limits. There were 7 subjects who had an E-2 ^level consider- 
ably below the 150 pmd/L required for the midfollicular 
phase, and 5 subjects who had P levels below 30 nmol/L 
required for the midluteal phase. Retesting of these 
individuals on subsequent cycles yielded E-2 and P levels 
within the general expected range. One participant #15, 
known to be taking oral contraceptives, had relatively 
stable levels of E-2 and P throughout her cycle. Her phase 
of cycle therefore could not be confirmed by hormone assay. 
For her tests, the data were collected at day 7 and day 21, 
as if the phases were correctly assigned. 
The perceived exertion of each of the subjects carrying 
out a submaximal task was found to be unaffected by the 
phase of menstrual cycle. The mean RPE at minute 12 on day 
1 was 14.36, for the midfollicular phase 14.04, and for the 
midluteal phase it was 14.07. This non-effect of phase on 
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RPE for submaximal work was confirmed by a one-way analysis 
of variance set out in Table 6, This is in agreement with 
Stephenson et al (1982), who found no statistically signifi- 
cant changes in RPE at any exercise intensity related to the 
cycle phase of healthy women. 
These observations are not in conflict with those of 
Gamberale et al (1975) who found that subjects who suffered 
severe menstrual distress, reported greater RPE while 
carrying out submaximal work loads during menses than during 
pre- or post-menstrual periods. Unlike those of Gamberale, 
subjects in this study experienced 'normal* premenstrual 
tension and discomfort and were able to carry out assigned 
tasks without significant discomfort on day 1 of menses. 
Lactic acid accumlations may help to explain the 
insignificant changes in RPE when performing a standard task 
at different phases of the menstrual cycle. Lactic acid, 
present in the blood in the form of lactate, is the end 
product of anaerobic metabolism, and its level is inversely 
related to oxygen availability. Morgan (1973) believes 
lactic acid accumulation plays a major role in the perception 
of muscle fatigue. After having reached exhaustion, a delay 
of a few minutes is necessary before levels in circulating 
blood reflect the rate of diffusion from working muscles 
(Burke, Fleck and Dickson, 1981; De Bruyn-Prevost and 
Sturbois, 1980; Diamont, Kalson and Saltin, 1968). Diamont 
et al (1968) and Burk et al (1981) recommend measures of 
lactic acid at 2 and 5 minutes after completion of a work 
task. 
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Table 6 indicates that no significant differences were 
observed in lactic acid levels produced by either submaximal 
or maximal work in any of the three phases of the cycle. 
Mean levels of lactic acid 2 minutes after the submaximal 
run were 2.47, 2.39 and 2.54 mmol/L for day 1, midfollicular 
and midluteal phases respectively, and mean lactic acid 
levels 5 minutes after the run-to-exhaustion were 8.94, 8.96 
and 9.24 mmol/L for day 1, midfollicular and midluteal 
phases respectively. 
The insignificant difference in lactic acid production 
in any phase of the menstrual cycle following the run to 
exhaustion, is contrary to that found by Jurkowski (1982). 
She observed that plasma lactic acid levels produced by 
heavy exercise in the follicular phase were higher than 
levels produced by the same exercise in the luteal phase. 
These differences persisted for at least 5 minutes into the 
recovery phase. The heavy exercise reported by Jurkowski 
consisted of 20 minutes of exercise at 60-70% of the indi- 
vidual's work capacity. Blood samples were collected from 
an indwelling catheter during the exercise, as well as at 5 
and 10 minutes into recovery. Only after 10 to 15 minutes 
into the heavy exercise did levels of plasma lactate in the 
follicular phase significantly increase above the level in 
the luteal phase. 
The 6 minute period of work at 80% of capacity in this 
study may not have been long enough for influence of phase 
to affect the lactic acid level. 
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Findings of other investigations support the conclusion 
that RPE for submaximal work load is not influenced by phase 
of cycle. Higgs and Robertson (1981) found no statistical 
difference in RPE for day 1 versus midcycle performance of 
work at 90% VO2 max. Only when performing at 100% VO2 Max 
did their subjects register a significant increase in RPE at 
day 1 over the RPE at midcycle. Stephenson et al (1982) 
found no significant changes in RPE at any exercise intensity 
that could be related to cycle phase. 
An interesting finding was the increase in maximum run 
times (MRT) to exhaustion in the midluteal phase in compari- 
son to MRT in either the midfoilicular phase or day 1 of 
menses. The average increase in MRT's in the midluteal 
phase over the MRT’s of day 1 was 15.4%. The average 
increase in MRT's in the midfollicular phase over the MRT's 
of day 1 was 6.8%. The only variation from this pattern was 
by subject #14, who recorded her poorest average run time 
during the midfollicular phase, and her best average MRT 
during the midluteal phase. The same pattern held true for 
subject #15 on oral contraceptives whose MRT in the midluteal 
phase was 8.0% higher than in the midfollicular phase. 
Less surprising was the average increase of 18.8% in 
MRT made in the midfollicular phase compared to MRT's 
registered on day 1 of menses. For subjects 1 to 14, the 
mean MRT was 268.9 seconds in the midfollicular phase versus 
226.1 seconds on day 1. A number of authors have observed 
impaired performance immediately prior to, and/or on first 
day of menstruation, Erdelyi (1962) reported extretnely poor 
42 
performance in tennis and rowing during menstrual periods, 
but unimpaired performance in track and field. Erdelyi went 
so far as to recommend that it was not adviseable to take 
part in any training or contests during mentruation. 
Doolittle and Engebretsen (1972) reported no cycle related 
change in three endurance performance tests which included a 
12 minute run, a 600 yard run, and a 1.5 mile run. 
The findings of this study suggest an impaired perfor- 
mance of 13 of 14 athletes running to voluntary exhaustion 
on the first day of menses. Only one subject, number 14, 
had a 6.5% longer MRT on day 1 of menses than that at the 
midfoilicular phase. It should be observed that subject #15 
who was taking oral contraceptives did not suffer a notice- 
ably poorer performance at day 1 as compared to her perfor- 
mance during other phases of her cycle. 
Jurkowski (1982) recorded a two-fold increase in time 
to exhaustion at 90% Wmax in the luteal phase over the 
follicular phase. This study found a significant but 
smaller difference in time-to-exhaustion at 100% work 
capacity in the two phases. The physical condition of 
Jurkowski’s ’physical education students' was possibly less 
than that of the competitive athletes in this study. 
The finding of a consistent increase in the MRT of 
athletes in the midfollicular and the midluteal phase over 
day 1, may have important implications for preparations for 
strenuous competition. One usually has no influence over 
the date of a competition, nor is it practical to attempt to 
postpone the onset of menstruation. The data of subject #15 
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suggests that the use of oral contraceptives might level out 
the performance over the three phases of the menstrual cycle. 
It remains to be determined whether their use reduces the 
performance in the midluteal phase to the performance level 
of day 1, or whether it elevates the performances on day 1 
to the level in the midluteal phase. Such might well be the 
subject of a future study on female athletes maintaining a 
training program before and after their acceptance of oral 
contraceptives on a regular schedule. 
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CHAPTER VI 
SUMMARY AND RECOMMENDATIONS 
Summary 
The purpose of this study was to identify and confirm 
biochemically the phases of the menstrual cycle in well- 
conditioned athletes and then to examine the effects of the 
various phases on work capacity, perceived exertion and 
lactic acid accumulation following individualized work 
tasks. Radioimmunoassays of plasma estradiol and proges- 
terone were used to confirm the midluteal and midfollicular 
phase of cycle. The phases in which tests were carried out 
were day 1 of flow, the midfollicular phase and the mid- 
luteal phase. The work load assigned to each subject was 
based on her individual maximum work capacity as determined 
by the Balke Treadmill Test. Perceived exertion was recorded 
using the Borg Scale while subjects completed a 12 minute 
run, 3 minutes at each of 60% and 70% of their maximum work 
capacity and the last 6 minutes at 80% of maximum work 
capacity. After a fifteen minute rest the subjects were 
asked to run as long as they could at a work rate correspond- 
ing to 100% of their maximum work capacity. 
Blood samples were drawn for lactic acid assays prior 
to the start of the initial run, 2 minutes after the sub- 
maximal run and again 5 minutes after the run to exhaustion. 
Fourteen healthy well conditioned athletes with 'normal 
cycles' and under no medication comprised the test group. A 
fifteenth athlete was also tested although she was regularly 
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taking oral contraceptives. Subjects were tested at each 
phase of 2 cycles in order to compare cycle to cycle scores. 
Data was obtained for perceived exertion, maximum run time 
and blood lactic acid levels. 
The phase of the cycles had no affect on perceived 
exertion or on the accumulation of lactic acid in any subject 
performing at 80% and 100% of her work capacity. 
The most apparent difference was the increase in the 
maximum run times. All subjects had improved run times in 
the midfollicular and midluteal phases over the run time on 
day 1 of flow. Also the run times in the midluteal phases 
were significantly greater than the run times in the mid- 
follicular phases. These differences were statistically 
significant at the P<0.05 level. 
No relationship could be found between the change in 
estradiol levels on day 1 and during the midluteal phase 
that could account for the subjects' ability to perform 
better in the midluteal phase. 
46 
Recommendations 
This author recommends that: 
A prospective trial be made to determine whether 
the adoption of an oral contraceptive regime would 
allow a subject to increase her work capacity on 
day 1 of menses to the level attained in the 
midluteal phase before the oral contraceptive was 
adopted, or whether the regular use of an oral 
contraceptive would limit the midluteal perfor- 
mance to that of Day 1 of flow. The information 
obtained from such a study might have important ~ 
implications for preparation of female athletes 
for strenuous competitive events. 
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APPENDIX A 
Questionnaire On Menstrual Cycle 
You have indicated interest in participating in a proposed 
research study concerning certain aspects of performnce and the 
menstrual cycle. Your assistance would be of great importance and 
would be deeply appreciated. The time required for participation 
will be approximately eight hours over a two to three month period. 
Under these conditions would you be willing to volunteer as a 
subject for this study? 
CHECK:   Yes   No 
The following information is essential in determining the 
final seledtion of subjects. All information given will be 
considered strictly confidential. 
NAME:    BIRTODATE: month/year:   
PHONE NUMBER: 
1. Is your menstrual period regular?    Yes   No 
a) Number of days between the onset of two successive 
menstrual periods.   
b) Average length of your menstrual period.  
c) Anticipated date of your next menstrual period.  
2. Do you experience discomfort during your menstrual period? 
  Yes No 
a) Check any of the following discomforts which you 
experience: 
   Abdominal cranps Others:  
  Backache   
  General discomfort  
  Unusual tension   2 
_____ Headache 
_____ Leg cranps 
  Tiredness 
b) Discomfort during first day.   Yes  No 
c) Discomfort during first and second day. 
  Yes 
  No 
3. Do you usually decrease the amount of physical activity 
during the first day of your menstrual period? 




HUMAN PERFORMANCE ASSESSMENT CENTRE 
Department of Physical Education 
University of Regina 
CLIENT HISTORY QUESTIONNAIRE A 
To Be Completed by Physician 
FOR PARTICIPATION IN GENERAL FITNESS ASSESSMENT 
PATIENT'S NAME  DATE  
Last First Initial 
ADDRESS   PHONE  
BIRTH DATE / /  AGE   
Day Month Year 
I consider the above individual as: “Normal" 
  Cardiac Patient 
  Prone to Coronary Heart Disease 
  Other (Explain)  
A) DIAGNOSTIC DATA ETIOLOGIC 
1. No heart disease 
2. Rheumatic heart disease 
Congenital heart disease 
^4. Hypertension 
5. Ischemic heart disease 
6. Heart Murmurs or Gallops 
7- Other 
B) PRESENT PHYSICAL ACTIVITY 
1. Very Act Ive 
2. Moderately Active 
3. Active 
A. Inactive 




1. Within Normal Limits 
2. Drug Effect 
Only (eg. digitalis) 
3- Abnormal 
a) Non Specific 





(Type and Treatment) 
3. Pacemaker Type 
SPECIFIC CARDIAC DIAGNOSIS 
NONE 
ANY ADDITIONAL ABNORMALITIES YOU ARE AWARE OF AND DATE DIAGNOSED 
PRESENT MEDICATIONS OR TREATMENTS 
PREVIOUS SIGNIFICANT MEDICAL HISTORY (PLEASE COMMENT) 
ACCIDENTS   
ALLERGIES    









V. Please fill in the information below if it is available: 
1. Blood count: Hbg.  
2. ECG, 12 lead (enclose copy)    
3. Blood pressure, Syst._  Diast.  (Medicated  Unmedicated ) 
4. Glucose mg. % 
5. Cholestrerql mg.% 
Fasting Triglyceride mg.% 
6. Graded Exercise Test Results (if available, enclose) 
Impression of above information  
VI) DATE OF LAST COMPLETE PHYSICAL EXAM AND DIAGNOSIS 
5b 
APPENDIX B 
Borg's 15 Point Scale 
for 
Ratings of Perceived Exertion 
6. 
7. Very, very light 
8. 
9. Very light 
10. 
11. Fairly light 
12. 




17. Very hard 
18. 




immuno-BSTRADIOi'.. iodine-125 kit 
PANTF.X (147 
I. Intended use 
Pantex immuno- ^ kits are designed for quantitive serum 
analysis by properly qualified laboratory personnel. They are used 
o ly "For in vitro diagnostic use." 
II. Principles of the method 
This radiounmunoassay method depends upon competition between the 
radio-labeled ligand in the tracer reagent and unlabeled ligand in 
the standard, control or sample for a constant and limiting 
concentration of antibody binding sites provided in the 1st 
antiserum. The unlabeled ligand in the incubation mixture reduces 
the amount of labeled ligand bound to the antibody. There is a 
quantitative relationship between the concentration of unlabeled 
ligand in the sample or standard and the proportion of tracer bound 
to the antibody. Ihe ligand-antibody ccmplex (the bound) is 
precipitated by the 2nd antiserum. Counts of the precipitated 
ligand are measured in a gamma counter after removal of the 
supernatant. Binding values of the standards are plotted vs. 
concentrations and the best line is drawn through the points. The 
binding values of the controls or samples are plotted on the line. 




1. Add 600 microliters of samples to screw-cap tubes. Add 6.0 ml 
of ethyl acetate:hexane (3:2). Tighten Teflon-lined caps and 
shake vigorously for 60 seconds. Centrifuge the tubes, or 
simply allcw layers to separate (approximately 5 minutes). 
2. Transfer 5.0 ml of each upper layer into glass scintillation 
vials or tubes. Be careful not to contaminate them with any of 
the lower layer. Evaporate extracts to dryness with air or 
nitrogen. Use of a 40-50^C bath will increase the rate of 
evaporation. 
3. To each vial add 1,25 ml of diluent. Cover. Let stand for 30 
o 
minutes at 37 C and mix before analysis. (Each 0.5 ml of 
reconstituted extract (recon. extr.) contains the equivalent of 
200 microliters of the original serum sample.] 
4. Use of 1.2 or 1.8 ml of serum will give greater sensitivity for 
samples with low E2 concentrations (e.g. prepubertal or 
postmenopausal). An additional factor is required in the 
calculation: see VIII.5. 
.Standard dilution 
Since standards in buffer are rot stable for extended periods, 
dilutions must be made just prior to each run. Pipet carefully in 
all the following steps. Pipet 100 microliters of stock standard 
into a 10 ml volumetric flask. Add diluent up to 10 ml. Mix. The 
E2 concentration is 512 pg/ml: equivalent to 1280 pg of E2/ml of 
serim in samples. 
To each of 7 tubes labeled 640, 320, 160, 80, 40, 20, and 10 add 
2.0 ml of diluent. Hake serial 2-fold dilutions by pipetting 2.0 
ml of the 1280 pg/ml standard to the 640 tube. After mixing, pipet 
2.0 ml from the 640 tube to the 320 tube, etc. Concentrations of 
✓ 
all these diluted standards are expressed as their serum 
equivalents. The actual weight of E2 pipetted into tubes is 
5B 
indicated in Table 1. 
RIA procedure 
Allow reagents to come to room temperature and mix them gently just 
before use. See the flew sheet in Table 1. Label tubes for: 
total Gountr non-specific binding (NSB), standards, control sera 
and unknowns. The nunber of standard and sample replicates per run 
is determined by each laboratory. Since the total count tubes 
contain only the tracer, these may be capped or stoppered and 
recounted for subsequent assays in which the same bottle of tracer 
is used. 
The reagents are color coded. After .addition of reagent at each 
step all tubes will have the same color, if the proper reagents 
have been added to each tube. The proper mixed color is indicated 
below and also on the flow sheet. It is obvious if a reagent has 
not been added to one of the tubes. The total count tubes are the 
only exceptions: they remain yellow since only the yellcw tracer 
is add^ to them. 
1. Pipet 500 microliters of diluted standards Or recon. extr. of 
samples into the tubes. Add 500 microliters of diluent to NSB 
and zero std. tubes. 
tubes-colorless 
2. Pipet 100 microliters of diluted tracer into each tube, 
tubes-yellow 
^ • Pipet 100 microliters of 1st antiserun into each tube, except 
to total count and NSB tubes. 
5y 
tubes-green 
4. Add 100 inicroliters of NSB buffer to each NSB tube. 
tubes-green 
4a. Mix tubes gently. Incubate tubes at 37 C for a minimum of 30 
minutes. — 
5. Add 500 microiiters of 2nd antiserum to each tube, except to 
total count tubes. 
tubes-brown 
6. Mix tubes gentily and leave them at room temperature for 10 
minutes. 
7. Centrifuge cubes at 2500 RCF x G fOr 10 minutes. Aspirate or 
decant and discard each supernatant without disturbing the 
precitipate. Absorb any liquid on the lip of the tube with 
^ tissue. Any liquid left in tlie tube included unbound 
radioactivity. If an appreciable volume of liquid remains, an 
apparent high B/BO value will be obtained. This could cause 
lew values at the lowest ligand levels. 
8. Count all tubes: total; and precipitates of NSB, standards, 
controls, and unknowns. Determine the background count. 
IV. Calculation 
Subtract the mean NSB count from each corrected count (except 
6U 
total) to obtain net counts> (Corrected count is the gross count 
minus background.) ^untsjused in the calculation bela^ are net 
counts. As an example of data calculation, see Table 2, the data 
table from an experimental run, and Fig. 1, on which the results of 
standards are plotted. Calculation using the logit-log plot (17) 
is as follows; 
1. Calculate the relative percent bound (%B/B0) of each standard, 
i.e. of each standard relative to the zero standard. 
%B/B0 = counts of standard x 100 
counts of zero standard 
2. Plot on logit-log graph paper the points relating these 
calculated %E/B0 values and standard concentrations. Draw the 
best line through the points. 
3. Calculate %B/bO of the controls and samples. 
%B/B0 = counts of unknown x 100 
counts of zero standard 
4. Plot the %B/B0 values on the line. Project these points to the 
X-axis to obtain the ligand concentrations. 
5. V^en volumes of serum either greater or less than 600 
microliters have teen extracted, the E2 concentration obtained 
from VIII. 4 must be multiplied by a factor: 
factor = 600 — 
microliters of serum extracted 
61 
or using the column extraction: 
factor = ^00 _    _ 
microliters of serum added to the column 
V. Limitations of the procedure 
If an E2 value does not lie within the standard range, make an 
appropriate dilution of the recon. extr. with diluent and 
repeat the analysis. Multiply the concentration from VIII.4 or 
VIII.5 by the dilution factor to obtain the serum E2 level. 
1. The cross reactivities of the antiserum were measured based on 
50% displacement of labeled E2 by chemically related 
compounds. 
relative 
2. compound activity (%) 
estradiol-17beta 100 
estradiol-17alpha 1.4 
estriol under 0.018 
Conpounds with values under 0.001% were: androstenedione, 
cholesterol, corticosterone, cortisol, DHEA, estrone, 
pregnenolone, orogesterone, testosterone. 
3. Solvent loss before aliquotting in step 2 in the tube 
extraction should be minimized because evaporation of 
considerable solvent may result in a total volume less than 
6 ml, the aliquotting of more than 5/6 of the solvent, and 
therefore higher values. Tubes should not be allowed to stand 
without tops for extended periods after solvent is added or during 
aliquotting. 
4. Solvent suitability It is desirable to check blanks and 
recoveries on new lots of the hexane and ethyl acetate used for 
extraction to assure that they don't contribute significant 
amounts of apparent E2 to samples of lew concentration. If 
necessary, blank can be eliminated by redistilling the solvent 
in an all glass apparatus. 












up to 35,000 
350-750 
therapeutic range 
postmenopausal or castrate 
on oral contraceptives 
5.0-18.0 









Coat-A-Count Progesterone is a no extraction, solid phase 
radioimmunoassay designed for the quantitative 
measurement of progesterone in serum. It is intended strictly 
for in vitro use as an aid in clinical diagnosis. 
Catalog Numbers: TKFGl (100 tubes) TKPG2 (200 tubes) 
The 100 tube kit contains not more than 4 microcuries (148 
kilobecquerels) of radioactiveI Progesterone. The 
200 tube kit contains not more than 8 microcuries (296 
kilobecquerels). 
Methodology 
In the Coat-A-Count progesterone procedure, 
labeled progesterone competes with progesterone in the patient 
sample for sites on progesterone-specific antibody immobilized 
to the wall of a polypropylene tube. After incubation for a 
fixed time, isplation of the antibody-bound fraction is 
achieved simply by decanting tho supernatant. The tube is then 
counted in a gamma counter, the counts being inversely related 
to the amount of progesterone present in the patient sample. 
The coated cube, methodology offers significant 
gains in convenience compared to liquid-phase and tritiated 
systems, while maintaining the highest standards of accuracy 
and reliability. There is only one reagent to dispense, and no 
need for centrifugation. The kit features total counts of 
approximately 50,000 cpn(at iodination) and a maximuT\ binding 
of approximately 45 to 50%. The calibrators, which are shipped 
in liquid form, ready to use, have been prepared in processed 
human serun. Ihe calibration curve is linear, in a logit-loy 
representation, throughout the 0.1-40 ng/ml (0.3-127 nmol/1) 
range of the calibrators. 
Reproducibility is excellent, as documented in the 
Ferformance Data section below. The assay is sensitive to as 
little as 0.05 ng/ml progesterone. The immobilized antiserum 
is highly specific for progesterone, as shown by the table of 
crossreactivities. Accuracy has been confirmed by recovery of 
progesterone from spiked human serum. The kit's freedom from 
'matrix effects' is demonstrated by patient scaling experiments 
and by studies, presented in this protocol, on the effect of 
bilirubin, hemolysis and lipemia. 
Radioimmunoassay Procedure 
All components must be at normal room temperature prior to 
use. 
Plain Tubes: Label four plain(uncoated) 12 x 75mm 
polypropylene tubes T (total counts) and NSB (nonspecific 
binding) in duplicate. 
Coated Tubes; Label fourteen Progesterone Antibody-Coated 
Tubes A (maximum binding) and B through G in duplicate. 
Label additional antibody-coated tubes, also in duplicate, 
for each control and patient sample. 
2. Pipet 100 ul of the zero calibrator A into the NSB and A 
tubes, and 100 ul of each of the calibrators B through G 
into correspondingly labeled tubes. Pipet 100 ul of each 
control and patient sample into the tubes prepared, 
3. Add 1.0 ml of Buffered Progesterone to every 
tube. Vortex briefly and gently. 
4. Incubate for 3 hours at room temperature. 
5. Decant thoroughly. 
6. Count for 1 minute in a gamma counter. 
Calculation 
To calculate progesterone concentrations from a logit-log 
representation of the calibration curve, first determine for 
each pair of tubes the average NSB-corrected counts per 
minute: 
Net Counts = Average CFM minus Average NSB CFM 
Then determine the binding of each pair of tubes as a 
percent of maximum binding (MB), with the NSB-corrected counts 
of the A tubes taken as 100%: 
Net Counts 
Percent Bound = Net MB Counts x TOO . 
Using the log it-log graph paper provided with the kit, 
plot percent Bound on the vertical axis against Concentration 
on the horizontal axis for each of the calibrators B through G, 
and draw a straight line approximating the path of these six 
points. Progesterone concentrations for the unknowns may then 
be estimated from the line by interpolation. 
Expected Values: Serum Progesterone 
A 'normal range' study was performed at a large hospital 
laboratory using the Coat-A-Count Progesterone kit. The 
population was screened to exclude wcmen with fertility 
problems. Note that the mid-luteal samples constitute a subset 





Median Absolute Range (n) 
0.1 0.0 - 0.4 (24) 
Females: 
Follicular Phase 0.4 
•Luteal Phase 8.5 
Mid-Luteal Phase 23.2 
Over 60 Years Old 0.1 
























The data indicate that progesterone values transiently 
increase many fold during the middle of the luteal phase of the 
menstrual cycle. In pregnancy the general tendency is for 
values to increase. Ninety percent of the values for pregnancy 
fell in the ranges 13-35, 25-105, and 65-200 ng/ml for the 
first/ second and third trimesters, respectively. There is 
considerable interpersonal variation in progesterone values 
particularly in groups associated with elevated levels. Here 
it should be stated again that many investigators consider the 
measurement of progesterone levels unsuitable for monitoring 
fetal health in the later weeks of pregnancy. 
Other laboratories should takes these results as 
guidelines only. Because of differences which may exist 
between laboratories and locales in respect of population. 
diet, laboratory technique and selection of reference groups, 
it is important for each laboratory to establish by similar 
means the appropriateness of adopting the normal ranges 
suggested by this study. 
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APPENDIX E 
Lactic Acid Assay 
(Calbiochem-La Jolla, California) 
Test 
LDH 
L-lactate + NAD —lyruvate + NADH 
pyruvate Trapping Reaction 
GPT 
pyruvate + L-glutamate —-^-L-alanine + «c-KG 
Abbreviations: 6^-KG = ^-Ketoglutarate 
GPT = Glutamate pyruvate transaminase 
LDH = Lactate dehydrogenase 
NAD = Nicotinamide-adenine dinucleotide 
NADH = Nicotinamide-adenine dinucleotide, 
reduced. 
In this reaction, lactate is oxidized to pyruvate and a molar 
equivalent of NAD is reduced. The pyruvate formed in the 
reaction is converted to alanine in the GPT reaction thus 
pulling the LDH reaction to completion. The change in 
absorbance at 340 nm is proportional to the concentration of 
lactate in the sample. 
Reagent Composition 
"A" vials (reagent), when reconstituted according to 










"B" vials (cofactor), when reconstituted according to 
instructions, will yield approximately 
NAD 3.1 X 10-3 moles/liter 
Non-reactive stabilizer 
U.S. Patent 3,573,171 and foreign patents. 
Precautions 
Vial contents may be under vacuum. If there is any indication 
moisture has penetrated the seal, discard cne vial in 
question. 
Reconstitution of the Reagents 
A. Stat-Pack TM(Cat. No. 869218) 
1. Reconstitute the contents of one of the B vials 
(cofactor) with 15 ml of distilled water. Cap and invert 
gently. 
2. Open one of the A-vials and transfer the entire 
contents of the B vial into it. Cap and invert gently. 
Specimen Collection and Preparation for Analysis 
1. To 2 ml of ice-cold 0.6M perchloric acid in a centrifuge 
tube, add 1 mi of whole blood, plasma, serun or other type of 
specimen. Mix well by thoroughly shaking while keeping the 
mouth of the tube covered with Parafilm. Let stand for 5 
minutes at 3000 rpm. Use the supernatant for the assay. 
Lactic acid levels in blood increase due to breakdown of 
glucose after the blood is drawn. If blood is cooled and spun 
within 15 minutes of collection, the plasma is stable at -20 C 
for 38 days. It has been reported that glycolysis is arrested 
for 24 hours at 4*C in blood collected in fluoride-oxalate(3). 
Lactic acid has been reported to be stable in perchloric 
acid filtrates of oxalated blood for one week at 30‘^C(3), 
Interfering Substances 
A number of drugs and substances affect the rapid lactate 
assay. Young, et al, (4) have published a comprehensive list of 
such substances. 
Assay 
1. Using a suitable pipet, dispense 2,9 ml of the prepared 
reagent into a clean, dry cuvet with a 1 cm light path. 
2. Using water as a blank, make ail measurements at 340 nm. 
3. Place the cuvet in a constant-temperature waterbath for 3 
minutes or as long as needed to bring the reagent to the 
established temperature. Fteincubate the sample for the 
same length of time in the same bath. Calbiochem 
reconmends this test be performed at 30^C. 
4. Wipe the cuvet dry and imnediately insert into the 
temperature-controlled cell compartment of the photcameter. 
A constant temperature must be maintained while obtraining 
assay values. 
5. Measure the initial absorbance (Ao) of the reagent. 
6. Add 0.100 ml (100 Ul) of sample to the cuvet. Mix quickly 
by gentle inversion with a square of Parafilm over the 
mouth of the cuvet. Avoid shaking as this can trap air 
bubbles in the solution. Replace the cuvet in the constant 
temperature waterbath. Simultaneously, start a timer. 
7. After 15 minutes read the final absorbance (A15). 
8. If plasna is used and the net absorbance change of the 
sample is greater than 1.15, repeat the test using less 
sample. If a protein-free filtrate is used and the net 
absorbancre change for the sample is greater than 0.4, 
repeat the test using less sample. In either case, use the 
dilution factor D to conpensate for the dilution. 
Calculation 
A. For Protein-free filtration: 
Lactecacid concentration in mg/dL = AA x 131 x D, AA is the 
observed change in absorbance after the reaction has proceeded to 
ccmpletion. 131 is the conversion factor. A is a dilution factor. 
Tl 
APPENDIX F 




Max Run Timer Lactic Acid, 
Estradiol and Progesterone Values 
Subject: 
